DUBLIN–(BUSINESS WIRE)–The “Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th – Apr 30th, 2026)” training has been added to ResearchAndMarketsDUBLIN–(BUSINESS WIRE)–The “Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th – Apr 30th, 2026)” training has been added to ResearchAndMarkets

Understanding Active Pharmaceutical Ingredients (APIs): Online Training Course (Apr 29-30, 2026) – Enhance Your API Expertise with In-Depth GMP and GDP Training – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th – Apr 30th, 2026)” training has been added to ResearchAndMarkets.com’s offering.

An active pharmaceutical ingredient (API) or drug substance is any substance or mixture of substances intended to be used in the manufacture of a medicinal product, which is intended to furnish pharmacological activity, or have another direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or affect the structure and function of the body.

This course has been designed to provide attendees with a fundamental understanding of best practice and the regulatory environment applicable to active pharmaceutical ingredients in the pharmaceutical industry. It will cover key terminology, the EU and USA regulatory framework, Good Manufacturing Practice (GMP) requirements including controls and validation, and consider Good Distribution Practice (GDP) and how to manage your supply chain. Practical exercises will form part of the course to aid the learning process.

This is an essential and valuable introduction to the manufacture of APIs.

Benefits of Attending:

  • Gain a comprehensive overview of the API regulatory framework
  • Enhance your understanding of the key terms used in API manufacture
  • Recognise how Good Manufacturing Practices (GMP) apply to API synthesis
  • Understand the different approaches between small-molecule and large molecule processing
  • Learn how to manage the risk associated with your supply chain

Who Should Attend:

  • New entrants to those individuals working in a GxP environment
  • Quality management manufacturing specialists
  • Regulatory compliance specialists
  • Pharmaceutical technical professionals
  • Pharmaceutical professionals looking to enhance their Continuous Professional Development (CPD)

Agenda: Day 1

Introduction to APIs

  • Terminology and acronyms
  • Globalisation
  • Introduction to the regulatory framework

Methods and equipment – Part 1

  • Chemical synthesis
  • Reactors
  • Isolation
  • Drying
  • Exercise: managing particle size

Methods and equipment – Part 2

  • Biological
  • Fermentation
  • Harvesting
  • Exercise: impurities

Good Manufacturing Practice (GMP)

  • Requirements
  • Regulations
  • EU
  • FDA
  • Exercise: similarities and differences

GMP requirements (continued)

  • Pharmaceutical Quality System
  • Validation and Qualification
  • Outsourcing
  • Exercise: specialist or generalist

Supply chain considerations

  • Falsified Medicines Directive (FMD)
  • Good Distribution Practice (GDP) for APIs
  • Exercise risk mitigation

Agenda: Day 2

Introduction and recap

Registration aspects of production and control

  • The registration process
  • The Common Technical Document (CTD)
  • Active substance/drug master files
  • Exercise: strategy

Laboratory controls

  • Good Quality Control Laboratory Practice (GQCLP)
  • Validation
  • Stability
  • Exercise: data Integrity

Process validation

  • Purpose of validation
  • General considerations
  • Exercise: critical attributes

Cleaning validation

  • Cleaning strategy
  • Key requirements
  • Residues
  • Exercise: purpose

API control packaging materials

  • What to consider
  • Data requirements
  • Extraction, interaction, migration and sorption
  • Toxicology
  • Exercise: environmental factors

Wrap up and Q&A

For more information about this training visit https://www.researchandmarkets.com/r/ydcok1

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Market Opportunity
aPriori Logo
aPriori Price(APR)
$0.10853
$0.10853$0.10853
-1.59%
USD
aPriori (APR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

XRP Price Prediction: Ripple CEO at Davos Predicts Crypto ATHs This Year – $5 XRP Next?

XRP Price Prediction: Ripple CEO at Davos Predicts Crypto ATHs This Year – $5 XRP Next?

XRP has traded near $1.90 as Ripple CEO Brad Garlinghouse has predicted from Davos that the crypto market will reach new highs this year. Analysts have pointed
Share
Coinstats2026/01/22 04:49
What Is Jawboning? Jimmy Kimmel Suspension Sparks Legal Concerns About Trump Administration

What Is Jawboning? Jimmy Kimmel Suspension Sparks Legal Concerns About Trump Administration

The post What Is Jawboning? Jimmy Kimmel Suspension Sparks Legal Concerns About Trump Administration appeared on BitcoinEthereumNews.com. Topline Legal experts have raised concerns that ABC’s decision to pull “Jimmy Kimmel Live” from its airwaves following the host’s controversial comments about the death of Charlie Kirk, could be because the Trump administration violated free speech protections through a practice known as “jawboning.” Jimmy Kimmel speaks at Disney’s Advertising Upfront on May 13 in New York City. Disney via Getty Images Key Facts Disney-owned ABC announced Wednesday Kimmel’s show will be taken off the air “indefinitely,” which came after ABC affiliate owner Nexstar—which needs Federal Communications Commission approval to complete a planned acquisition of competitor Tegna Inc.—said it would not air the program due to Kimmel’s comments Monday regarding Kirk’s death and the reaction to it. The sudden move drew particular concern because it came only hours after FCC head Brendan Carr called for ABC to “take action” against Kimmel, and cryptically suggested his agency could take action saying, “We can do this the easy way or the hard way.” While ABC and Nexstar have not given any indication their decisions were influenced by Carr’s comments, the timing raised concerns among legal experts that the Trump administration’s threats may have unlawfully coerced ABC and Nexstar to punish Kimmel, which could constitute jawboning. Jawboning refers to “the use of official speech to inappropriately compel private action,” as defined by the Cato Institute, as governments or public officials—who cannot directly punish private actors for speech they don’t like—can use strongman tactics to try and indirectly silence critics or influence private companies’ actions. The practice is fairly loosely defined and there aren’t many legal safeguards dictating how violations of it are enforced, the Knight First Amendment Institute notes, but the Supreme Court has repeatedly ruled it can be unlawful and an impermissible First Amendment violation when it involves specific threats. The White…
Share
BitcoinEthereumNews2025/09/19 07:17
Wormhole Unleashes W 2.0 Tokenomics for a Connected Blockchain Future

Wormhole Unleashes W 2.0 Tokenomics for a Connected Blockchain Future

TLDR Wormhole reinvents W Tokenomics with Reserve, yield, and unlock upgrades. W Tokenomics: 4% yield, bi-weekly unlocks, and a sustainable Reserve Wormhole shifts to long-term value with treasury, yield, and smoother unlocks. Stakers earn 4% base yield as Wormhole optimizes unlocks for stability. Wormhole’s new Tokenomics align growth, yield, and stability for W holders. Wormhole [...] The post Wormhole Unleashes W 2.0 Tokenomics for a Connected Blockchain Future appeared first on CoinCentral.
Share
Coincentral2025/09/18 02:07